Skip to main content
. 2014 Apr 10;2014(4):CD008965. doi: 10.1002/14651858.CD008965.pub4

NCT00419263.

Methods Evaluation of the efficacy and safety of peramivir in subjects with uncomplicated acute influenza
Sponsor: BioCryst Pharmaceuticals
Participants
Interventions Peramivir
Outcomes
Notes Awaiting assessment as we do not yet have the clinical study reports for this study